State of New Jersey Common Pension Fund D’s Bicara Therapeutics BCAX Stock Holding History

State of New Jersey Common Pension Fund D’s Portfolio BCAX Stock Details BCAX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$283K	Buy	+9,526	New	+$213K	﹤0.01%	1677

Other funds holding BCAX

RTM

Red Tree Management Redwood City, California $147M AUM 202.18% 1-Year Est. Return

NFT

Nan Fung Trinity Central, Hong Kong, Hong Kong $1.01B AUM 64.38% 1-Year Est. Return

Walleye Capital New York $28B AUM 44.22% 1-Year Est. Return

TD Asset Management Toronto, Ontario, Canada $115B AUM 41.58% 1-Year Est. Return

SAM

SEB Asset Management Stockholm $26.6B AUM

HealthInvest Partners Stockholm, Sweden $372M AUM 59.89% 1-Year Est. Return

ALPS Advisors Denver, Colorado $21.3B AUM 23.41% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

Ascent Group Virginia Beach, Virginia $3.34B AUM 27.33% 1-Year Est. Return

State of New Jersey Common Pension Fund D's BCAX Position: Q2 2026 in Review

State of New Jersey Common Pension Fund D opened a new position in Bicara Therapeutics (BCAX) in Q2 2026: 9,526 shares worth $283K. The stake represents ﹤0.01% of the portfolio and ranks #1677 among its holdings.

28 funds tracked by Wall St. Rank hold BCAX as of Q2 2026.

State of New Jersey Common Pension Fund D held 9,526 shares of Bicara Therapeutics worth $283K as of Q2 2026.
Bicara Therapeutics was a new State of New Jersey Common Pension Fund D position in Q2 2026.
Bicara Therapeutics made up ﹤0.01% of State of New Jersey Common Pension Fund D's portfolio in Q2 2026, its #1677 holding.
28 funds tracked by Wall St. Rank held Bicara Therapeutics as of Q2 2026.

Based on State of New Jersey Common Pension Fund D's 13F filing for Q2 2026, filed 4 Aug 2026.